Welcome to our dedicated page for Chemed news (Ticker: CHE), a resource for investors and traders seeking the latest updates and insights on Chemed stock.
Chemed Corporation (symbol: CHE) is a diversified holding company that operates through its two significant subsidiaries: VITAS Healthcare Corporation and Roto-Rooter Services Company. With its headquarters in Cincinnati, Ohio, Chemed’s operations are concentrated in the United States, where it generates the majority of its revenue.
VITAS Healthcare Corporation is one of the leading providers of hospice care services in the nation. Specialized in end-of-life care for terminally ill patients, VITAS offers comprehensive palliative care through a dedicated network of professionals including physicians, registered nurses, home health aides, social workers, and volunteers. The revenue for this segment comes predominantly from Medicare and Medicaid reimbursement programs, making it a substantial part of Chemed’s financial structure.
On the other hand, Roto-Rooter Services Company is the largest provider of plumbing, drain cleaning, and water restoration services in the United States. Catering to both residential and commercial customers, Roto-Rooter ensures 24/7 services to meet urgent and routine plumbing needs. This segment also plays a crucial role in Chemed’s revenue generation, supporting the company’s diversified business model.
Chemed Corporation has showcased resilience and strong financial health through consistent performance improvements and strategic expansions. Recent achievements include significant growth in the VITAS segment, driven by an increase in the number of patients served and enhanced operational efficiencies. Additionally, Roto-Rooter’s revenue growth has been fueled by robust demand for emergency plumbing services and effective market penetration strategies.
With a forward-looking approach, Chemed continues to expand its footprint in the healthcare and plumbing services sectors through innovations, strategic acquisitions, and partnerships. The company’s long-term vision focuses on delivering high-quality, reliable services to meet the evolving needs of its diverse customer base.
Chemed (NYSE: CHE) reported its Q4 2024 financial results, showing mixed performance across its two main segments. Consolidated revenue increased 9.2% to $640.0 million, with GAAP EPS rising 2.0% to $6.02 and Adjusted EPS up 3.5% to $6.83.
VITAS Healthcare, their hospice care division, demonstrated strong growth with revenue increasing 17.4% to $411.0 million, driven by a 14.6% increase in Average Daily Census and a 3.5% rise in Medicare reimbursement rates. The segment completed an $85.0 million acquisition of Covenant Health's hospice assets in April 2024.
Roto-Rooter segment showed declining performance with revenue decreasing 2.9% to $229.0 million and Adjusted EBITDA falling 7.2% to $60.3 million. The company's 2025 guidance projects earnings per diluted share of $24.95 to $25.45, compared to $23.13 in 2024.
Chemed (NYSE:CHE) has declared a quarterly cash dividend of 50 cents per share, maintaining the same level as the previous quarter's payment. The dividend will be paid on March 14, 2025, to shareholders of record as of February 24, 2025.
This marks Chemed's 215th consecutive quarterly dividend in its 53-year history as a public company. The company operates through two wholly owned subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE: CHE) has announced it will release its fourth-quarter 2024 financial results on February 26, 2025, after the NYSE trading close. The company will host a conference call and webcast on February 27, 2025, at 10 a.m. ET to discuss quarterly results and provide a business update.
Participants can access the event through Chemed's investor relations website or via teleconference registration. A replay will be available approximately two hours after the call through the company's website.
Chemed operates two main subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
Chemed (NYSE:CHE) has announced its participation in the 43rd Annual JPMorgan Healthcare Conference. The presentation is scheduled for Tuesday, January 14, 2024, at approximately 10:30 a.m. PST and will take place at the Westin St. Francis Hotel in San Francisco, CA.
The event will be accessible through a live webcast on Chemed's website (www.chemed.com) under the Investor Relations section. A replay of the webcast will be available approximately three hours after the live presentation and will remain accessible for 90 days.
Chemed , headquartered in Cincinnati, Ohio, operates two major subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the country's leading provider of plumbing and drain cleaning services.
Chemed (NYSE:CHE) has announced its participation in the BofA Securities 2024 Virtual Home Care Conference scheduled for Tuesday, December 10, 2024, at 1:20 PM (ET). The presentation will be available via live webcast through Chemed's website and will remain accessible for 90 days after the event.
Chemed operates through two main subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States. The company is headquartered in Cincinnati, Ohio, and is listed on the New York Stock Exchange.
Chemed (NYSE:CHE) has announced two significant financial decisions: First, its Board of Directors has authorized an additional $300 million for stock repurchase under the existing share repurchase program, to be funded through operational cash flow and revolving credit facility. Second, the board declared a quarterly cash dividend of 50 cents per share, payable on December 6, 2024, to shareholders of record as of November 18, 2024. This marks Chemed's 214th consecutive quarterly dividend in its 53-year history as a public company.
Chemed (NYSE: CHE) has announced its participation in the UBS 2024 Global Healthcare Conference. The presentation is scheduled for Tuesday, November 12, 2024, at 2:45 p.m. (ET) at the Terranea Resort in Rancho Palos Verdes, California. The event will be webcast live through Chemed's website, with presentation materials available online. A replay will be accessible within 24 hours and available for 90 days.
Chemed operates two main subsidiaries: VITAS Healthcare, the largest provider of end-of-life hospice care in the nation, and Roto-Rooter, the leading provider of plumbing and drain cleaning services.
Chemed (NYSE: CHE) reported Q3 2024 financial results with consolidated revenue increasing 7.4% to $606.2 million. GAAP Diluted EPS rose 1.4% to $5.00, while Adjusted Diluted EPS increased 6.0% to $5.64.
VITAS Healthcare showed strong performance with net patient revenue up 17.3% to $391.4 million, driven by a 15.5% increase in Average Daily Census. Roto-Rooter experienced declines with revenue decreasing 6.9% to $214.8 million.
The company revised its 2024 guidance, projecting full-year adjusted earnings per diluted share between $23.00 and $23.15, representing a 13.3% to 14.0% increase from 2023.
Chemed (NYSE: CHE) has announced its schedule for releasing third-quarter 2024 financial results. The company will disclose its earnings on Tuesday, October 29, 2024, after the New York Stock Exchange closes. Following this, Chemed will host a conference call and webcast on Wednesday, October 30, 2024, at 10 a.m. ET to discuss the quarterly results and provide a business update.
Investors and analysts can access the live webcast through Chemed's investor relations website or via a specific hosting link. Teleconference registration is also available. A taped replay of the call will be accessible approximately two hours after its conclusion through Chemed's investor relations website.
Chemed , headquartered in Cincinnati, Ohio, operates two subsidiaries: VITAS Healthcare, the largest provider of end-of-life hospice care in the US, and Roto-Rooter, the leading national provider of plumbing and drain cleaning services.
Chemed (NYSE:CHE) has announced a 25% increase in its quarterly cash dividend, raising it from 40 cents to 50 cents per share. The dividend will be payable on August 30, 2024, to shareholders of record as of August 12, 2024. This marks Chemed's 213th consecutive quarterly dividend in its 53 years as a public company. The previous dividend increase was in August 2023, from 38 cents to 40 cents per share.
Chemed operates two wholly owned subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.
FAQ
What is the current stock price of Chemed (CHE)?
What is the market cap of Chemed (CHE)?
What is Chemed Corporation?
What services does VITAS Healthcare provide?
What does Roto-Rooter Services Company do?
Where does Chemed Corporation generate most of its revenue?
How is the VITAS segment financed?
What recent achievements has Chemed Corporation accomplished?
What is the main focus of Chemed Corporation's long-term vision?
Who are the primary customers of Roto-Rooter Services?
Where is Chemed Corporation headquartered?
What is the significance of Chemed's diversified business model?
